BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23821456)

  • 1. MCM3 protein expression in follicular and classical variants of papillary thyroid carcinoma.
    Igci YZ; Erkilic S; Igci M; Arslan A
    Pathol Oncol Res; 2014 Jan; 20(1):87-91. PubMed ID: 23821456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole Tumor Capsule Is Prognostic of Very Good Outcome in the Classical Variant of Papillary Thyroid Cancer.
    Giani C; Torregrossa L; Ramone T; Romei C; Matrone A; Molinaro E; Agate L; Materazzi G; Piaggi P; Ugolini C; Basolo F; Ciampi R; Elisei R
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4072-e4083. PubMed ID: 34231847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Septin 7 immunoexpression in papillary thyroid carcinoma: a preliminary study.
    Igci YZ; Erkilic S; Arslan A
    Pathol Res Pract; 2014 Jul; 210(7):426-31. PubMed ID: 24685401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follicular variant of papillary carcinoma: reproducibility of histologic diagnosis and utility of HBME-1 immunohistochemistry and BRAF mutational analysis as diagnostic adjuncts.
    Wallander M; Layfield LJ; Jarboe E; Emerson L; Liu T; Thaker H; Holden J; Tripp S
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):231-5. PubMed ID: 20042852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discriminatory miRNAs for the Management of Papillary Thyroid Carcinoma and Noninvasive Follicular Thyroid Neoplasms with Papillary-Like Nuclear Features.
    Jahanbani I; Al-Abdallah A; Ali RH; Al-Brahim N; Mojiminiyi O
    Thyroid; 2018 Mar; 28(3):319-327. PubMed ID: 29378472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.
    Dettmer M; Perren A; Moch H; Komminoth P; Nikiforov YE; Nikiforova MN
    Thyroid; 2013 Nov; 23(11):1383-9. PubMed ID: 23427895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
    Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
    Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genotyping of the non-invasive encapsulated follicular variant of papillary thyroid carcinoma.
    Kim TH; Lee M; Kwon AY; Choe JH; Kim JH; Kim JS; Hahn SY; Shin JH; Chung MK; Son YI; Ki CS; Yim HS; Kim YL; Chung JH; Kim SW; Oh YL
    Histopathology; 2018 Mar; 72(4):648-661. PubMed ID: 28940583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Bizzarro T; Martini M; Capodimonti S; Straccia P; Lombardi CP; Pontecorvi A; Larocca LM; Rossi ED
    Cancer Cytopathol; 2016 Oct; 124(10):699-710. PubMed ID: 27717284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Greek family with a follicular variant of familial papillary thyroid carcinoma: TCO, MNG1, fPTC/PRN, and NMTC1 excluded as susceptibility loci.
    Tsilchorozidou T; Vafiadou E; Yovos JG; Romeo G; McKay J; Lesueur F; Bonora E
    Thyroid; 2005 Dec; 15(12):1349-54. PubMed ID: 16405407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up.
    Giani C; Torregrossa L; Piaggi P; Matrone A; Viola D; Molinaro E; Agate L; Romei C; Ugolini C; De Napoli L; Materazzi G; Basolo F; Elisei R
    Endocrine; 2020 Jun; 68(3):607-616. PubMed ID: 32124258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minichromosome maintenance protein 3 is a candidate proliferation marker in papillary thyroid carcinoma.
    Lee YS; Ha SA; Kim HJ; Shin SM; Kim HK; Kim S; Kang CS; Lee KY; Hong OK; Lee SH; Kwon HS; Cha BY; Kim JW
    Exp Mol Pathol; 2010 Feb; 88(1):138-42. PubMed ID: 19818763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytopathology of non-invasive follicular thyroid neoplasm with papillary-like nuclear features: A comparative study with similar patterned papillary thyroid carcinoma variants.
    Mahajan S; Agarwal S; Kocheri N; Jain D; Mathur SR; Iyer VK
    Cytopathology; 2018 Jun; 29(3):233-240. PubMed ID: 29638022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the embryonic morphogen Nodal in differentiated thyroid carcinomas: Immunohistochemistry assay in tissue microarray and The Cancer Genome Atlas data analysis.
    Chai YJ; Kim YA; Jee HG; Yi JW; Jang BG; Lee KE; Park YJ; Youn YK
    Surgery; 2014 Dec; 156(6):1559-67; discussion 1567-8. PubMed ID: 25456955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological roles of alterations of tumor suppressor gene p16 in papillary thyroid carcinoma.
    Lam AK; Lo CY; Leung P; Lang BH; Chan WF; Luk JM
    Ann Surg Oncol; 2007 May; 14(5):1772-9. PubMed ID: 17195959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Situ Hybridization Analysis of miR-146b-5p and miR-21 in Thyroid Nodules: Diagnostic Implications.
    Guo Z; Hardin H; Montemayor-Garcia C; Asioli S; Righi A; Maletta F; Sapino A; Lloyd RV
    Endocr Pathol; 2015 May; 26(2):157-63. PubMed ID: 25771986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features Accounts for More Than Half of "Carcinomas" Harboring RAS Mutations.
    Paulson VA; Shivdasani P; Angell TE; Cibas ES; Krane JF; Lindeman NI; Alexander EK; Barletta JA
    Thyroid; 2017 Apr; 27(4):506-511. PubMed ID: 28114855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
    Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
    Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.